Baaz, Marcus http://orcid.org/0000-0002-5098-017X
Cardilin, Tim
Lignet, Floriane
Zimmermann, Astrid
El Bawab, Samer
Gabrielsson, Johan
Jirstrand, Mats
Funding for this research was provided by:
merck kgaa
stiftelsen för strategisk forskning
Chalmers University of Technology
Article History
Received: 5 September 2021
Accepted: 27 April 2023
First Online: 6 May 2023
Declarations
:
: The study designs and animal usage for the xenograft studies were approved by local animal welfare authorities (Regierungspräsidium Darmstadt, Germany, protocol numbers DA4/Anz. 397, DA4/Anz. 398, and DA4/Anz.1014).
: Not applicable.
: FL is an employee of Merck Healthcare KGaA, Darmstadt, Germany.AZ is an employee of Merck Healthcare KGaA, Darmstadt, Germany.SB was an employee of Merck Healthcare KGaA, Darmstadt, Germany, at the time of the study.